To learn more about the general aims of the REACH registry, the global nature of atherothrombosis, its potential clinical manifestations in the coronary, cerebral, and peripheral vasculature, and its associated risk factors, read the overview brochure.
For a more detailed review of the pathophysiology, epidemiology, and cost burden of atherothrombosis, as well as disease management and how to identify patients at risk, you can review the comprehensive guide. Here you will also find more about the scope of the REACH registry, the study design, selection of subjects, and inclusion and exclusion criteria.
